Literature DB >> 10830194

Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients.

S Chabrier1, B Husson, P Lasjaunias, P Landrieu, M Tardieu.   

Abstract

This paper describes 59 patients, 3 months to 16 years of age, who were seen consecutively in the same center for cerebral arterial infarction. It focuses on the mechanism of stroke. The pathophysiologic process could be established for 78% of the children. Arteriopathic stroke (31 patients, or 53%) was the most common. The arteriopathies were either progressive (moyamoya in 4 patients, or 7%) or nonprogressive (27 patients, or 46%). The latter form occurred in two patterns: dissection of cervicocephalic arteries (12 patients, or 20%) and transient cerebral arteriopathy of unknown origin but probably angiitis (15 patients, or 25%). Cardiac or transcardiac embolic stroke occurred in 12% of the series and systemic diseases in 14%. There was a favorable outcome in 70% of patients having stroke due to nonprogressive arterial disease and stroke due to unidentified mechanisms. In contrast, only 26% of patients with embolic stroke, systemic disease, or moyamoya had a favorable outcome. Recurrences were more frequent and severe in this latter group. It is concluded that it is important to determine the mechanism of childhood stroke, because it strongly influences outcome, the recurrence risk, and treatment choice.

Entities:  

Mesh:

Year:  2000        PMID: 10830194     DOI: 10.1177/088307380001500504

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  34 in total

1.  Paediatric acute basilar thrombosis successfully treated with intravenous alteplase.

Authors:  Paulo Rego Sousa; Rui Vasconcellos
Journal:  BMJ Case Rep       Date:  2012-05-08

2.  Unilateral a(1) and m(1) occlusions in a child with trisomy 21.

Authors:  P Corr; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-10-15       Impact factor: 1.610

Review 3.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

4.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation.

Authors:  Stephen Osiro; Christopher Wear; Ryan Hudson; Xiao-Xiao Ma; Anna Zurada; Maciej Michalak; Marios Loukas
Journal:  Surg Radiol Anat       Date:  2012-05-03       Impact factor: 1.246

Review 6.  Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations.

Authors:  Lauren A Beslow; Lori C Jordan
Journal:  Childs Nerv Syst       Date:  2010-07-13       Impact factor: 1.475

7.  Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence.

Authors:  Heather J Fullerton; Gabrielle A deVeber; Nancy K Hills; Michael M Dowling; Christine K Fox; Mark T Mackay; Adam Kirton; Jerome Y Yager; Timothy J Bernard; Eldad A Hod; Max Wintermark; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-08-04       Impact factor: 7.914

8.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

9.  The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort.

Authors:  M A Gardner; N K Hills; S Sidney; S C Johnston; H J Fullerton
Journal:  Neurology       Date:  2010-01-06       Impact factor: 9.910

10.  Pediatric stroke in the United States and the impact of risk factors.

Authors:  Warren Lo; Julie Stephens; Soledad Fernandez
Journal:  J Child Neurol       Date:  2009-02       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.